当前位置: 首页 > 期刊 > 《中国医学创新》 > 2012年第30期 > 正文
编号:12317959
经皮冠状动脉介入诊疗术并发造影剂肾病的临床观察(2)
http://www.100md.com 2012年10月25日 章敬水 程久佩 邵名亮
第1页

    参见附件。

     参考文献

    [1] Thomsen H S.Guidelines for contrast media from the European Society of Urogenital Radiology[J].AJR Am J Roentgenol,2003,181(6):1463—1471.

    [2] Liistro F,Falsini G,Bolognese L.The clinical burden of contrast media—induced nephropathy[J].Ital Heart J,2003,4(10):668—676.

    [3] Haller C,Hizoh I.The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro[J].Invest Radiol,2004,39(3):149—154.

    [4] Russo D,Minutolo R,Cianciaruso B,et al.Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure[J].J Am Soc Nephrol,1995,6(5):1451—1458.

    [5] Katholi R E,Woods WT Jr,Taylor G J,et al.Oxygen free radicals and contrast nephropathy[J].Am J Kidney Dis,1998,32(1):64—71.

    [6] Hizoh I,Haller C.Radiocontrast—induced renal tubular cell apoptosis:hypertonic versus oxidative stress[J].Invest Radiol,2002,37(8):428—434.

    [7] Mueller C,Buerkle G,Buettner H J,et al.Prevention of contrast media—associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty[J].Arch Intern Med,2002,162(3):329—336.

    [8] Wróbel W,Sinkiewicz W,Gordon M,et al.Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions[J].Kardiol Pol,2010,68(9):1015—1020.

    (收稿日期:2012—06—18) (本文编辑:李静)

您现在查看是摘要介绍页,详见PDF附件(1503kb)